Indian pharma firms eye US oncology market amid surge in FDA approvals, FDI boost
Daijiworld Media Network – New Delhi New Delhi, Apr 18: Indian pharmaceutical companies are intensifying their push into the rapidly expanding US oncology generics market, now valued at $145 billion and growing at 11% annually, a new report reveals. …